Welcome to the Ackermann Lab!
Our lab studies islet cell biology using mouse models, cell lines, and primary human tissue to investigate islet cell dysfunction in diabetes (type 1 and type 2) and congenital hyperinsulinism. Our goal is to identify novel pathways regulating beta cell insulin secretion, leading to innovative therapeutic strategies for these disorders. Current studies include a combination of in vivo mouse physiology, ex vivo human islet physiology, CRISPR-Cas9 gene editing, epigenetic modification, and single-cell functional genomics.
The Ackermann lab is currently seeking post-doctoral fellows and rotation students.
Post-doctoral fellow applicants ideally will have a PhD in molecular biology or a related field at the time of hire. Candidates should have good communication skills and have at least one first-author manuscript in a peer-reviewed journal either published or accepted. Experience with standard techniques such as molecular cloning, immunohistochemistry, animal models (especially mouse), tissue culture, high throughput sequencing, and/or bioinformatics is preferred.
For more information regarding a post-doctoral position and to apply, please click here.